Home > Products > CD3 & CD38
> Recombinant Anti-CD3 x Anti-CD38 sdAb Bispecific Antibody (IgG-sdAb)
Recombinant Anti-CD3 x Anti-CD38 sdAb Bispecific Antibody (IgG-sdAb) (CAT#: IGVHH-052)
Recombinant Anti-CD3 x Anti-CD38 Bispecific Antibody (IgG-sdAb) is designed to be expressed as a LC and an extended HC with a sdAb linked to the C terminus. It is a symmetric bispecific and tetravalent molecule, bivalent for each antigen specificity, 2+2 antigen-binding valency. This BsAb can retarget T cells to CD38+ cancer cells. It is designed for the research of Multiple myeloma (MM) therapy. As required, the sdAb can also be fused to the C terminus of the LC.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-CD38 sdAb Bispecific Antibody (IgG-sdAb) (IGVHH-052). Click the button below to contact us or submit your feedback about this product.